These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 3623046)

  • 1. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
    Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
    Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
    Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
    Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
    Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
    Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
    Chan YM; Ng TY; Ngan HY; Wong LC
    Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
    Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.